Skip to main content
Caplight Logo









Biohope

Biohope

Private
MadridHealthcare & Life Scienceshttps://biohope.eu/

Last Round

VC Round

May 14, 2026

Total Funding Raised

$22.66M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Biohope is a biotechnology company that develops precision medicine diagnostic tools to personalize and optimize immunosuppressive therapy for transplant and autoimmune patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

precision medicinein vitro diagnosticIVDimmunosuppressionpersonalized medicineorgan transplantrheumatoid arthritisdiagnostic kitdrug sensitivityclinical decision supportbiotechcompanion diagnosticsimmunologygraft survivalmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biohope Comparables

Compare Biohope with similar companies based on industry and business-model similarity.

Biohope comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Verici Dx plc
77%
BIOSYNEX
71%
Scipher Medicine
69%

Biohope Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 14, 2026
GrantJan 10, 2025
GrantSep 1, 2024
DebtOct 14, 2023
CrowdfundingJan 10, 2018

Key People

Founding team and executive leadership

Isabel Portero

Founder. President of the Company Board. Chief Scientific Chief Innovation Officer

Founding Team

Francisco Javier Tejera Bustos

Cfo

Executive Team

Biohope Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 40% MoM.

  • Jun 17, 2026

    Monthly visitors increased 47% MoM.

Biohope Filings

Explore SEC and related filing metadata, where available.

Biohope filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biohope's valuation, stock price, and market status.

Is Biohope a public or private company?

Biohope is a private company.

What is the current stock price of Biohope?

Biohope is a private company with no public stock price. Caplight tracks Biohope's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Biohope worth (valuation)?

Valuation information for Biohope is not publicly available.

Can I buy Biohope stock?

Biohope shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Biohope's last funding round?

Biohope's most recent funding round was VC Round on May 14, 2026.

Who are the main investors in Biohope?

Key investors in Biohope include European Investment Bank Group, Community of Madrid, Center for Technological Development and Innovation, National Kidney Foundation.

Will Biohope IPO soon?

No public IPO plans have been announced for Biohope.

How can I track Biohope secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biohope's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMadrid
Employee Range23
Year Founded2015
Last FundingMay 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?